Evidence map›Paper›PMID 38020340›Full record

ArticleBreathe (Sheffield, England)2023

Lung Science Conference highlights 2023: Post-viral lung diseases - from basic immunology to clinical phenotypes and therapy.

Sara Cuevas Ocaña, Chiara DeSanti, Katie Daly, Christina Shrees, Nimród László, Carla Bellinghausen, Carola Voss, Joana Cruz

Abstract read
In one paragraph

Article in Breathe (Sheffield, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Preview of the Lung Science Conference 2024.Breathe (Sheffield, England) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sara Cuevas OcañaBiodiscovery Institute, School of Medicine, University of Nottingham, Nottingham, UK.ORCID https://orcid.org/0000-0002-8326-5279
Chiara DeSantiSchool of Pharmacy and Biomolecular Sciences, Royal College of Surgeons, Dublin, Ireland.
Katie DalyPriority Research Centre for Healthy Lungs, University of Newcastle Australia, New Lambton Heights, Australia.
Christina ShreesBiodiscovery Institute, School of Medicine, University of Nottingham, Nottingham, UK.
Nimród LászlóMures County Clinical Hospital, Pulmonology, Târgu Mureș, Romania.
Carla BellinghausenDepartment of Respiratory Medicine/Allergology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany.
Carola VossInstitute of Lung Health and Immunity, Helmholtz Center Munich, Munich, Germany.
Joana CruzCenter for Innovative Care and Health Technology (ciTechCare), School of Health Sciences (ESSLei), Polytechnic of Leiria, Leiria, Portugal.ORCID https://orcid.org/0000-0002-4911-4469

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38020340
PMCPMC10644106

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.